Ionis Pharmaceuticals: The Ion-ARPA initiative (White papers)

Selected teams will design and develop a novel, multifaceted, scalable, non-immunogenic strategy to deliver complex macromolecular therapeutic payloads to specific target cells and tissues. The payload must be delivered into the target cells in a biologically active form that can induce phenotypic and/or genotypic changes and enable healing for the patient.

Funding: Annual funding could range from seedlings of $300K to full programs of $1M per laboratory, with appropriate justification.

https://www.ionispharma.com/ionis-innovation/ion-arpa-initiative/?sap-outbound-id=6DF0AF74881FBC495BF92D8F2A6A9C0761CEF6DF